Fewer serious complications. Fewer hospitalizations and blood transfusions. Better growth and development. And a markedly ...
In this GEN webinar, Erdinc Sezgin, PhD, Karolinska Institutet, will present how his lab profiled plasma membrane order ...
Exclusive: Demand for blood to treat the rare disorder has soared by 132% in 10 years Demand for blood needed to treat rare disorders such as sickle cell has soared by more than 130% in 10 years, ...
Please provide your email address to receive an email when new articles are posted on . Two studies highlight the potential of gene editing for sickle cell disease treatment. Despite increasing ...
The first patient in Louisiana to receive genetically edited therapy for sickle cell disease went home this week after months in isolation at Manning Family Children's Hospital in New Orleans. Daniel ...
Medical history has been made in Louisiana. On Tuesday, the first person in the state to receive gene therapy for sickle cell disease left the hospital after a six-week-long stay. The hope is that ...
Two scientists whose work ushered in the first approved therapy using the gene-editing tool CRISPR have won the $3 million Breakthrough Prize in Life Sciences. The prize winners — Dr. Swee Lay Thein ...
A major step forward for sickle cell care in Georgia is now awaiting the governor's signature. On the final day of the 2026 legislative session, lawmakers passed House Bill 334 — known as the "Sickle ...
Tatyana Thompson found a successful experimental treatment for the genetic condition at 30 years old Getty Tatyana Thompson was diagnosed with sickle cell disease when she was 2 months old and endured ...
Sickle cell disease is often thought of solely as a blood disorder, but new research from the Wood Neuro Research Group provides measurable evidence that it can reshape how brain networks function.
On her best days, Tatyana Thompson’s pain was at a level five. Some days, it would stay that way, a persistent throb in her joints, her hands, her back. On other days, if she was dehydrated or was hit ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This voice experience is generated by AI. Learn more. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results